Bloomage Biotechnology Corp Ltd. Stock Analysis 688363.SS

Bloomage Biotechnology Corp. Ltd. engages in the production of hyaluronic acid, sodium hyaluronate bulk drugs, and medical supplements through fermentation. The company is headquartered in Jinan, Shandong and currently employs 3,698 full-time employees. The company went IPO on 2019-11-06. The firm's products include raw materials, medical end products, functional skincare products, and functional foods. Raw materials include a series of bioactive products centered around hyaluronic acid, applied in pharmaceutical materials, personal care products, nutrition and health, and innovative business areas. Medical end products are divided into medical aesthetics and pharmaceutical categories, including ophthalmic viscoelastic agents, medical lubricants, soft tissue fillers, and medical skin protectants. Functional skincare products include single-use ampoules, various creams, lotions, masks, and hand masks. Functional foods include hyaluronic acid solutions and hyaluronic acid-based foods.